首页 | 本学科首页   官方微博 | 高级检索  
检索        

附子质量控制研究进展
引用本文:昝珂,过立农,马双成,刘杰,郑健,高妍.附子质量控制研究进展[J].中国药事,2019,33(7):767-773.
作者姓名:昝珂  过立农  马双成  刘杰  郑健  高妍
作者单位:中国食品药品检定研究院, 北京 100050,中国食品药品检定研究院, 北京 100050,中国食品药品检定研究院, 北京 100050,中国食品药品检定研究院, 北京 100050,中国食品药品检定研究院, 北京 100050,中国食品药品检定研究院, 北京 100050
基金项目:科技部国家科技重大专项(民口)课题重大新药创制“中药组分资源库及产业公共技术服务平台建设”(编号2018ZX09735-006)
摘    要:目的:对近年来附子的质量控制研究进展进行总结并提出相应建议,为有毒药材附子的质量控制及其监管提供参考。方法:采用查阅国内外相关文献、质量标准、炮制规范,进行归纳分析,对附子的质量研究进展进行综述。结果:附子的质量控制研究较多,药典标准基本能够起到控制其质量的作用。但还存在着一些地方炮制规范制订时间较早,方法存在一定的缺陷;很多含附子的成药中缺少完善的质控措施;附子饮片的质量参差不齐,缺少合理的质量分级标准;测定双酯型生物碱所需的乌头碱对照品较难获得等问题。结论:附子的质量控制有一定进展,但仍有较多问题亟待解决以保障人民用药的安全有效。

关 键 词:附子  质量控制  毒性  研究进展
收稿时间:2019/5/8 0:00:00

Research Progress in Quality Control of Radix Aconiti Lateralis Praeparata
Zan Ke,Guo Linong,Ma Shuangcheng,Liu Jie,Zheng Jian and Gao Yan.Research Progress in Quality Control of Radix Aconiti Lateralis Praeparata[J].Chinese Pharmaceutical Affairs,2019,33(7):767-773.
Authors:Zan Ke  Guo Linong  Ma Shuangcheng  Liu Jie  Zheng Jian and Gao Yan
Institution:National Institutes for Food and Drug Control, Beijing 100050, China,National Institutes for Food and Drug Control, Beijing 100050, China,National Institutes for Food and Drug Control, Beijing 100050, China,National Institutes for Food and Drug Control, Beijing 100050, China,National Institutes for Food and Drug Control, Beijing 100050, China and National Institutes for Food and Drug Control, Beijing 100050, China
Abstract:Objective:To summarize research progress of quality control of Radix Aconiti Lateralis Praeparata (Fuzi) in recent years and put forward corresponding suggestions in order to provide references for quality control and regulation of the toxic medicinal materials. Methods:The relevant literatures about quality standards and processing specifications at home and abroad were summarized and analyzed. The research progress of quality control of Fuzi was reviewed. Results:There were many studies on quality control of Fuzi. Pharmacopoeia standards could basically control its quality. But there were still some problems, such as the early formulation of local processing standards, the shortcomings of methods, lack of perfect quality control measures in many patent medicines containing Fuzi, uneven quality of decoction pieces, lack of reasonable quality classification standards, and difficulty of obtaining reference substances for the determination of diesteralkaloids. Conclusion:The quality control of Fuzi has made some progress, but there are still many problems to be solved urgently to ensure the safety and effectiveness of public medication.
Keywords:Radix Aconiti Lateralis Praeparata  quality control  toxicity  research progress
点击此处可从《中国药事》浏览原始摘要信息
点击此处可从《中国药事》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号